Our transcriptomic analysis did not support activation of DLX2, BRN3A, or NEUROD6 genes as being involved in the BMP4-induced phenotypes of neuroblastoma cells, as previously suggested by studies using BMP2 [22]. This evidence concerns the gene BMP2 and neuroblastoma.